Starling Oncology, Inc. (NASDAQ:STLN)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $587.2M
- Net income
- -$36.3M
- Net margin
- -6.2%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $104.5M
- Cash
- $41.1M
Covers near-term obligations, without much room.
- Current assets
- $129.0M
- Current liabilities
- $94.9M
- Current ratio
- 1.36
Roughly cash-neutral.
- Operating cash flow
- $328K
- Free cash flow
- -$3.3M
- FCF margin
- -0.6%
Share count history not available.
- Shares outstanding
- 103.0M
- Share growth (1y)
- —
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
STLN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | 161.28 M | 147.44 M | 141.96 M | 136.56 M |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | 134.12 M | 124.13 M | 119.19 M | 117.64 M |
| Gross Profit | 27.16 M | 23.32 M | 22.77 M | 18.92 M |
| SG&A Expense | 29.94 M | 28.21 M | 28.04 M | 25.25 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 31.78 M | 29.83 M | 29.67 M | 26.97 M |
| Operating Income | -4.62 M | -6.51 M | -6.91 M | -8.05 M |
| Pretax Income | -9.79 M | -2.49 M | -7.51 M | -16.50 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -9.79 M | -2.49 M | -7.51 M | -16.50 M |
| EPS (Basic) | -0.08 | -0.02 | -0.06 | -0.14 |
| EPS (Diluted) | -0.08 | -0.02 | -0.06 | -0.14 |
| Shares Outstanding | 103.03 M | 101.80 M | 101.46 M | 97.47 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.